Atlas Venture Fund XI, L.P. 13D/13G Filings for Xilio Therapeutics, Inc. (XLO)

Atlas Venture Fund XI, L.P. 13D and 13G filings for Xilio Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:30 pm
Sale		 2024-09-30 13G Xilio Therapeutics, Inc.
XLO		 Atlas Venture Fund XI, L.P. 0
0.000%		 -2,023,402decrease
(Position Closed)		 Filing
2021-11-05
4:43 pm
Purchase		 2021-10-26 13G Xilio Therapeutics, Inc.
XLO		 Atlas Venture Fund XI, L.P. 2,023,402
7.600%		 2,023,402increase
(New Position)		 Filing